ArticleOncotarget2016

Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation.

Yung Chang Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.